Urethral Cancer
📧 Sign up to get email alerts when something new happens for Urethral Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study assessing the combination of nivolumab, ipilimumab, and cabozantinib for various rare ge…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors [Phase 1]
Phase 1 trial of bortezomib in combination with gemcitabine and doxorubicin for urothelial cancer and other solid tumors; the study is curre…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy [Phase 1]
A Phase 1 clinical trial is investigating the combination of Erdafitinib and Enfortumab Vedotin for metastatic bladder/urothelial cancers af…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: 64Cu-GRIP B in Patients With Advanced Malignancies [Phase 1, Phase 2]
Clinical trial update for a Phase 1/Phase 2 study of 64Cu-GRIP B in advanced malignancies, including prostate and renal cancers, which is cu…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant [Phase 2]
Phase 2 clinical trial evaluating a four-drug combination—fluorouracil, leucovorin, gemcitabine, and cisplatin—for metastatic or unresectabl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-07-05Clinical Trial Update: Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
This clinical trial update reports on biomarker studies in patients with kidney cancer or urothelial cancers and in healthy participants.
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 trial evaluating Sunitinib malate in patients with locally recurrent, locally advanced, unresectable, or metastatic urinary tract ca…